Novare Capital Management LLC Has $398,000 Stake in CVS Health Corporation $CVS

Novare Capital Management LLC lowered its stake in shares of CVS Health Corporation (NYSE:CVS) by 89.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,280 shares of the pharmacy operator’s stock after selling 43,889 shares during the quarter. Novare Capital Management LLC’s holdings in CVS Health were worth $398,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Cantor Fitzgerald Investment Advisors L.P. raised its holdings in CVS Health by 1.6% in the 2nd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock valued at $28,264,000 after buying an additional 6,615 shares during the last quarter. Alpha Omega Wealth Management LLC increased its position in CVS Health by 12.3% in the 3rd quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock valued at $11,301,000 after acquiring an additional 16,418 shares during the period. Aaron Wealth Advisors LLC lifted its holdings in shares of CVS Health by 177.4% during the third quarter. Aaron Wealth Advisors LLC now owns 34,259 shares of the pharmacy operator’s stock worth $2,583,000 after purchasing an additional 21,911 shares during the period. Wealth Enhancement Advisory Services LLC grew its stake in shares of CVS Health by 186.6% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator’s stock worth $30,568,000 after purchasing an additional 258,050 shares during the last quarter. Finally, Red Mountain Financial LLC acquired a new stake in CVS Health in the second quarter valued at $293,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have commented on CVS shares. Truist Financial set a $100.00 target price on CVS Health in a report on Wednesday, December 10th. Jefferies Financial Group lifted their price objective on CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. TD Cowen increased their target price on shares of CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Finally, Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Twenty investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $94.82.

Trending Headlines about CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS shares rose while the broader market fell, reflecting short-term buying interest and risk-on flows. Zacks Article
• Positive Sentiment: Short interest fell ~13.4% in January to ~18.76M shares (1.5% of float), lowering potential downward pressure from short sellers and reducing squeeze risk (days-to-cover ~2.5). Short Interest Data
• Positive Sentiment: An executive vice president disclosed a small open-market buy (24 shares at ~$53.70 on Jan. 23), a modest insider signal of confidence. SEC Form 4
• Neutral Sentiment: Analysts at Argus cut their price target slightly from $91 to $90 but kept a “buy” rating (still showing material upside), signaling continued analyst support despite the trim. The Fly
• Neutral Sentiment: Bank of America lowered its target from $100 to $95 but maintained a “buy” stance, also implying continued conviction in longer-term upside despite near-term adjustments. Benzinga
• Negative Sentiment: The administration’s proposal to keep Medicare rates roughly flat has pressured Medicare-related revenue expectations for payers and pharmacy benefit managers, contributing to earlier selloffs and ongoing margin concerns for CVS. Barron’s
• Negative Sentiment: A House Judiciary report and related coverage allege CVS used tactics to limit competition from rival pharmacy hubs, introducing regulatory and legal risk that could increase compliance costs or fines. HealthcareDive

CVS Health Price Performance

Shares of CVS opened at $74.14 on Thursday. The firm has a market cap of $94.12 billion, a PE ratio of 195.11, a price-to-earnings-growth ratio of 0.66 and a beta of 0.48. CVS Health Corporation has a 52-week low of $53.36 and a 52-week high of $85.15. The business’s 50 day moving average price is $79.01 and its two-hundred day moving average price is $75.02. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. CVS Health’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.09 EPS. On average, equities analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.6%. The ex-dividend date of this dividend is Thursday, January 22nd. CVS Health’s payout ratio is 700.00%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.